UNSPSC 51294601: Minaprine

This classification denotes an antidepressant agent with the molecular formula C17H22N4O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 00U7GX0NLM, chemically known as 4-morpholineethanamine, n- (4-methyl-6-phenyl-3-pyridazinyl)-, dihydrochloride but generally known as minaprine, which bears US NIH Compound Identifier 4199. European Medicines Agency schedules Minaprine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08974MIG.

UNSPSC 51294601 Minaprine, a Commodity code, describes pharmaceutical products that state and local governments procure for public health and emergency response programs. Recent solicitations under this code show state and local buyers acquiring naloxone and drug deactivation systems to support community health initiatives and opioid overdose response. The scope encompasses the purchase and quarterly delivery of pharmaceutical agents and related medical supplies to public health facilities, with vendors responsible for shipping, storage compliance, and regulatory adherence including E-Verify and drug-free workplace certification. County health departments and community health boards are the primary issuing bodies under this code.

Seminole County, Florida posted an IFB (Invitation for Bid) in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response deadline, marking the most recent tracked activity under the code. The contract included a two-year initial term with a one-year renewal option, quarterly delivery to the Seminole County Community Health Building in Sanford, Florida, and potential FEMA funding with associated federal compliance requirements. The source reflects limited recent state and local procurement activity under this specific Commodity code; the single recent opportunity comes from Florida.